Seminars in Oncology

Article	Citations
Unlocking the therapeutic potential of polyphenols: Promising advances and future directions in pancreatic cancer treatment	40
Integrated analysis of scRNA-seq and bulk RNA-seq data identifies BHLHE40 as a key gene in pancreatic cancer progression and gemcitabine resistance	38
Hepatitis B Virus Reactivation in Cancer Patients Receiving Chemotherapy—A Systematic Review and Meta-Analysis	27
Airway disorders associated with immune checkpoint inhibitor therapy: Two case reports and a systematic review	24
Breaking barriers: Deciphering the mechanisms of Olaparib resistance in prostate cancer	21
Editorial Board	18
Military exposures and lung cancer in United States Veterans	16
Deciphering the US Regulatory Framework: Comparison Between Oncology Biosimilars and Reference Biologics	16
Global distribution of prophylactic total gastrectomy in E-cadherin (CDH1) mutations	15
Table of Contents	14
Explainable machine learning and feature interpretation to predict survival outcomes in the treatment of lung cancer	13
Editorial Board	12
Influence of Cancer on COVID-19 Incidence, Outcomes, and Vaccine Effectiveness: A Prospective Cohort Study of U.S. Veterans	12
Role of neoadjuvant pembrolizumab in advanced melanoma	12
Adenocarcinoma on retrorectal cystic hamartoma: An illustrative image for a very rare diagnosis	11
The interest of therapeutic and pharmacological drug monitoring of methotrexate: A systematic review	11
Advancing personalized medicine in LMICs: Predictive indicators for cervical cancer immunotherapy response	11
Editorial Board	11
Masthead	10
Assessment of PSA responses and changes in the rate of tumor growth -rate with immune checkpoint inhibitors in US Veterans with prostate cancer	10
Acute liver failure secondary to malignant infiltration: A single center experience	9
The knowns and unknowns of disparities, biology, and clinical outcomes in Hispanic and Latinx multiple myeloma patients in the U.S.	9
Breast cancer exosomes: Managing macrophage polarization and immune regulation in the tumor microenvironment	9
Masthead	9
Impact of the COVID-19 Pandemic on the Wellbeing of International Oncology and Hematology Fellows at the Princess Margaret Cancer Center (PMCC)	8

Treatment and outcomes of pediatric patients with cancer and COVID-19 at MAHAK pediatric cancer treatment and research center, Tehran, Iran	8
Editorial Board	8
Immune checkpoint inhibitors in patients with chronic kidney disease: Assessing their ability to cause acute kidney injury and informing their proper use	8
Treating patients with dihydropyrimidine dehydrogenase (DPD) deficiency with fluoropyrimidine chemotherapy since the onset of routine prospective testing—The experience of a large oncology center in t	7
Biomarkers and the microbiome in the detection and treatment of early-stage non-small cell lung cancer	7
Surgery for early-stage lung cancer with video-assisted thoracoscopic surgery versus open thoracotomy: A narrative review	7
The challenges of selecting cancer medicines for the WHO Essential Medicines List with the elephant in the room: A path forward	7
Primary adrenal insufficiency induced by immune checkpoint inhibitors: biological, clinical, and radiological aspects	6
Atezolizumab plus bevacizumab versus Lenvatinib for patients with Barcelona clinic liver cancer stage B (BCLC-B) hepatocellular carcinoma (HCC): A real-world population	6
Recent updates on novel heterocyclic scaffolds of anticancer potential as emerging tubulin inhibitors	6
Hexokinases in gastrointestinal cancers: From molecular insights to therapeutic opportunities	6
Barriers and facilitators to lung cancer screening and follow-up	6
Masthead	6
Screening Adherence for Second Primary Malignancies in Breast Cancer Survivors: Behaviors, Facilitators, and Barriers to Enhance Quality Care	6
Current and prospective antibody-based therapies in multiple myeloma	5
Editorial Board	5
Colorectal cancer in Ethiopia: Epidemiological trends, diagnostic and laboratory capacities, and challenges	5
Treating advanced lung cancer in older Veterans with comorbid conditions and frailty	5
A narrative review of the principal glucocorticoids employed in cancer	5
High tumor mutation burden mitigates the negative impact of chemotherapy history on immune checkpoint blockade therapy	5
Advances and challenges in cancer immunotherapy: Strategies for personalized treatment	5
outside front cover	5
Radiation recall dermatitis: A review of the literature	5
Exosomal circular RNAs as drivers of temozolomide resistance in glioblastoma: Mechanisms and implications	5
Managing multiple myeloma in a resource-limited region: Diagnosis and treatment in Armenia	4
Are we there yet? Gut microbiota for cancer diagnosis, prognosis and treatment	4
Daratumumab: A review of current indications and future directions	4
Masthead	4
CDK4/6 inhibitors in the treatment of metastatic breast cancer: Focus on toxicity and safety	4
Masthead	4
Cancer genetic mutation prevalence in sub-Saharan Africa: A review of existing data	4
Table of Contents	4
Efficacy of metformin drug in preventing metabolic syndrome associated with androgen deprivation therapy (ADT) in prostate cancer patients: A systematic review and meta-analysis	3
Assessing Outcomes in NSCLC: Radiomic analysis, kinetic analysis and circulating tumor DNA	3
Comorbidity and life expectancy in shared decision making for lung cancer screening	3
outside front cover	3
Masthead	3
TOC	3
The impact of the COVID-19 pandemic on tertiary care cancer center: Analyzing administrative data	3
Outside front cover	3
Communication strategies during the COVID-19 pandemic: Unforeseen opportunities and drawbacks	3
PARP inhibitors in ovarian cancer	3
Outcomes with panobinostat in heavily pretreated multiple myeloma patients	3
Outside front cover	2
Fingerprint change as a consequence of anticancer treatments: A systematic integrative review	2
TOC	2
Lung cancer screening at the VA: Past, present and future	2
outside front cover	2
Table of Contents	2
Synchronous or metachronous presentation of pancreatic neuroendocrine tumor versus secondary lesion to pancreas in patients affected by renal cell carcinoma. Systematic review	2

Examining health related quality of life outcomes in multiple myeloma: Past and future perspectives	2
Table of Contents	1
Overcoming barriers to opioid-induced constipation management in cancer patients	1
Lung cancer: Premalignant biology and medical prevention	1
TOC	1
Which future for de-intensified treatments in HPV-related oropharyngeal carcinoma?	1
The critical role of NLRP3 in drug resistance of cancers: Focus on the molecular mechanisms and possible therapeutics	1
Current perspectives, guiding lights to the future, and transforming care for patients with multiple myeloma	1
TOC	1
Non-small cell lung cancer in the era of immunotherapy	1
Outside front cover	1
Bleeding risk with concomitant administration of VEGF-TKIs and anticoagulant agents	1
The Crucial Nexus: Unveiling the Role of Collagen in Cancer Progression	1
Editorial Board	1
The dual effect of interferon-γ in acute myeloid leukemia: A narrative review	1
Scoping to analyze oncology trial participation in Australia	1
Editorial Board	1
Epidemiology and genetics of early onset colorectal cancer—African overview with a focus on Ethiopia	1
TOC	1
Immune-checkpoint inhibitors in anal squamous cell carcinoma: a systematic review and meta-analysis	1
Prevalence, mutational spectrum and clinical implications of clonal hematopoiesis of indeterminate potential in plasma cell dyscrasias	1
Divergent functions of TLRs in gastrointestinal (GI) cancer: Overview of their diagnostic, prognostic and therapeutic value	1
Editorial Board	1
Editorial Board	0
Controversies and challenges in lung cancer screening	0
TOC	0
Challenges in initiating a lung cancer screening program: Experiences from two VA medical centers	0
Masthead	0
CTLA-4 blockade in ovarian cancer immunotherapy: Mechanisms and clinical strategies	0
A systematic review and meta-analysis on non-metastatic castration resistant prostate cancer: The radiation oncologist's perspective	0
Complete response in a frail patient with high-grade B-cell lymphoma to only one cycle of R-CHOP or to prolonged COVID-19?	0
Evidence- and consensus-based guidelines for drug-drug interactions with anticancer drugs; A practical and universal tool for management	0
Skin metastases in the clinical and dermoscopic aspects	0
Masthead	0
outside front cover	0
TOC	0
The psychosocial and emotional experiences of cancer patients during the COVID-19 pandemic: A systematic review	0
Targeting EZH2 to overcome the resistance to immunotherapy in lung cancer	0
Integrated profile of tumor stage and mutational burden predicts disparate clinical responses to immune checkpoint inhibitors: A risk-benefit study	0
Liquid biopsy: An innovative tool in oncology. Where do we stand?	0
Importance, relevance, and pertinence of discussing mental health in the uro-oncology patient	0
Masthead	0
PARP inhibitors: A review of the pharmacology, pharmacokinetics, and pharmacogenetics	0
Masthead	0
outside front cover	0
Successful restoration of checkpoint inhibitors efficacy after allogeneic hematopoietic cell transplant for classic Hodgkin lymphoma patients	0
Editorial Board	0
Oral selective estrogen receptor degraders (SERDs): The new emperors in breast cancer clinical practice?	0
Identifying and closing information gaps in head and neck cancer surgery	0
Impact of CT screening in lung cancer: Scientific evidence and literature review	0
“Off-the-shelf” immunotherapies for multiple myeloma	0
Isolated lung metastases from pancreatic ductal adenocarcinoma (PDAC): Diagnostic and therapeutic challenges of a different disease	0
From doctors to ancillary staff: Regional and metropolitan cancer workforce perceptions and distress resulting from COVID-19 pandemic adaptations	0
LncRNA THUMPD3-AS1 promotes the proliferation and migration of esophageal cancer cells through the miR-29a-3p/ELK1/PRDX4 signaling pathway	0
Pioneering the Future of Oncology: A New Vision for Seminars in Oncology	0
Is the neutrophil-to-lymphocyte ratio a prognostic factor in non-small cell lung cancer patients who receive adjuvant chemotherapy?	0
Circular RNAs: Emerging regulators of signaling pathways in epithelial-mesenchymal transition and angiogenesis during breast cancer progression	0
Analysis of actionable genetic alterations in lung carcinoma from the VA National Precision Oncology Program	0
Tumor testing and treatment patterns in veterans with metastatic castration-resistant prostate cancer	0
Deep Myometrial Infiltration leads to a measurable Inflammatory Response in Endometrial Cancer. A Prospective Observational Study	0
outside front cover	0
Molecular biomarkers and liquid biopsies in lung cancer	0
outside front cover	0
Harnessing natural killer cells for the treatment of multiple myeloma	0
Efficacy of memantine in preventing neurocognitive dysfunction induced by radiation therapy in patients with brain metastases: A systematic review of clinical trials	0
Cancer stage and time from cancer diagnosis to first treatment during the COVID-19 pandemic	0
Mechanistic role of FTO in cancer pathogenesis, immune evasion, chemotherapy resistance, and immunotherapy response	0
Masthead	0
Defining genomic events involved in the evolutionary trajectories of myeloma and its precursor conditions	0
Gender-based differences in the efficacy of anti-EGFR/BRAF/MEK targeted therapy in patients with BRAF-mutated metastatic colorectal cancer	0
outside front cover	0
Lung Cancer Screening and Precision Oncology	0
Outside front cover	0
Dexamethasone to prevent everolimus-induced stomatitis (Alliance MIST Trial: A221701)	0
Masthead	0
Masthead	0
Table of Contents	0
Practice change: No benefit of extended lymphadenectomy at radical cystectomy in patients with muscle invasive bladder cancer	0
Seminars in oncology 50th anniversary	0
The emerging importance and evolving understanding of clonal hematopoiesis in multiple myeloma	0

IO-IO vs IO-TKI efficacy in metastatic kidney cancer patients: A structured systematic review over time	0
Maintenance or consolidation therapy in small-cell lung cancer: an updated systematic review and meta-analysis.	0
Novel targeted therapies for advanced non-small lung cancer	0
Loss of function STK11 alterations and poor outcomes in non–small-cell lung cancer: Literature and case series of US Veterans	0
A 3-miRNA signature for noninvasive breast cancer detection	0
CAR T-cell therapy: A collaboration between authorized treatment centers and community oncologists	0
Editorial Board	0
Cancer-specific mortality in patients with non-metastatic renal cell carcinoma who have undergone a nephrectomy and are eligible for adjuvant pembrolizumab	0
Masthead	0
Under-representation of women in Randomized Clinical Trials testing anticancer immunotherapy may undermine female patients care. A call to action	0
Modern radiographic imaging in multiple myeloma, what is the minimum requirement?	0
PARP1 roles in DNA repair and DNA replication: The basi(c)s of PARP inhibitor efficacy and resistance	0
Plant polyphenols in gastric cancer: Nature's healing touch	0
Exploring the clinical trials, regulatory insights, and challenges of PROTACs in oncology	0
Improved outcomes in women with BRAF-mutant melanoma treated with BRAF/MEK-targeted therapy across randomized clinical trials. A systematic review and meta-analysis	0
RENO Study: Clinical characteristics, treatment patterns and survival results in patients with metastatic renal cell carcinoma in Northern Spain	0
Practical guidance for new multiple myeloma treatment regimens: A nursing perspective	0
NTRK fusion-positive cancer in nonagenarian patient. The importance of comprehensive geriatric assessment in older people for the inclusion in clinical trials	0
The flaws in assessing and reporting the toxicities of oral targeted therapies	0
Peripheral blood CD4+CD25+ T lymphocytes and TGF-β predict the prognosis in relapsed/refractory multiple myeloma treated with daratumumab	0
Torticollis as a presenting symptom of pediatric CNS tumors: A systematic review	0
Beyond BRCA: Diagnosis and management of homologous recombination repair deficient pancreatic cancer	0
Chemotherapy plus immunotherapy as first line combination in older patients with extensive stage small cell lung cancer: A systematic review and meta-analysis	0
Epidemiology and prevention of gastric cancer: A comprehensive review	0
Real-world experience with CDK4-6 inhibition in the old and oldest old with a diagnosis of breast cancer	0
Bone-modifying agents for non–small-cell lung cancer patients with bone metastases during the era of immune checkpoint inhibitors: A narrative review	0
Invasive lobular breast cancer: Focus on prevention, genetics, diagnosis, and treatment	0
Table of Contents	0
PARP inhibitors for prostate cancer	0
Pathogenic signaling in multiple myeloma	0
Editorial Board	0
outside front cover	0
Editorial Board	0
TOC	0
The likelihood of being helped or harmed obtained from clinical trial results for cancer therapy: Can it really help?	0
Obesity correlates to the microsatellite instability of endometrial cancer: A retrospective observational study	0
TOC	0
Advancements and implications of artificial intelligence for early detection, diagnosis and tailored treatment of cancer	0
Battling chronic myeloid leukemia in a resource-constrained country: A case of public-private partnerships	0
Exploring the effects of racial and socioeconomic factors on timeliness of lung cancer diagnosis and treatment in Baltimore Veterans	0
Improving the efficacy of immunotherapy in small cell lung cancer: Leveraging recent scientific discoveries and tumor-specific antigens	0
Predictors of treatment refusal in patients with colorectal cancer: A systematic review	0
Editorial Board	0
COVID-19 vaccine-related axillary lymphadenopathy in breast cancer patients: Case series with a review of literature	0
Editorial Board	0
Non-pharmacologic interventions for improving cancer-related fatigue (CRF): A systematic review of systematic reviews and pooled meta-analysis	0
Masthead	0